Exclusive

Publication

Byline

Location

US Patent Issued to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on Sept. 22 for "Engineered T cell receptors and methods of use" (Texas Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,002, issued on Sept. 22, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas). "Engineered T cell receptors an... Read More


US Patent Issued to Hoffmann-La Roche on Sept. 22 for "Multistep final filtration" (German Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,003, issued on Sept. 22, was assigned to Hoffmann-La Roche Inc. (Branchburg, N.J.). "Multistep final filtration" was invented by Roberto F... Read More


US Patent Issued to Jiangsu Hengrui Medicine, SHANGHAI HENGRUI PHARMACEUTICAL on Sept. 22 for "Pharmaceutical composition containing antibody against IL-5 and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,004, issued on Sept. 22, was assigned to Jiangsu Hengrui Medicine Co. Ltd. (Lianyungang, China) and SHANGHAI HENGRUI PHARMACEUTICAL Co. LTD... Read More


US Patent Issued to SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) on Sept. 22 for "Human IL-33 antibodies, preparation method and conjugates thereof and method of use thereof for treatment" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,005, issued on Sept. 22, was assigned to SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) Co. LTD. (Shanghai). "Human IL-33 antibodies, preparat... Read More


US Patent Issued to KOBENHAVNS UNIVERSITET on Sept. 22 for "GLP1R agonist NMDAR antagonist conjugates" (Danish Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,006, issued on Sept. 22, was assigned to KOBENHAVNS UNIVERSITET (Copenhagen K, Denmark). "GLP1R agonist NMDAR antagonist conjugates" was i... Read More


US Patent Issued to Dyne Therapeutics on Sept. 22 for "Muscle-targeting complexes and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,007, issued on Sept. 22, was assigned to Dyne Therapeutics Inc. (Waltham, Mass.). "Muscle-targeting complexes and uses thereof" was invent... Read More


US Patent Issued to Shandong Boan Biotechnology on Sept. 22 for "CLDN18.2/CD3 bispecific antibodies for the therapy of CLDN18.2-expressing solid tumors" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,008, issued on Sept. 22, was assigned to Shandong Boan Biotechnology Co. Ltd. (Yantai, China). "CLDN18.2/CD3 bispecific antibodies for the... Read More


US Patent Issued to EVOPOINT BIOSCIENCES on Sept. 22 for "Antibody, antibody-drug conjugate thereof and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,009, issued on Sept. 22, was assigned to EVOPOINT BIOSCIENCES Co. LTD. (China). "Antibody, antibody-drug conjugate thereof and use thereof... Read More


US Patent Issued to First Tracks Biotherapeutics on Sept. 22 for "PD-1 agonist and method of using same" (California Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,010, issued on Sept. 22, was assigned to First Tracks Biotherapeutics Inc. (San Diego). "PD-1 agonist and method of using same" was invent... Read More


US Patent Issued to Verseau Therapeutics on Sept. 22 for "Anti-VSIG4 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,011, issued on Sept. 22, was assigned to Verseau Therapeutics Inc. (Bedford, Mass.). "Anti-VSIG4 compositions and methods for modulating m... Read More